Track: Hematology in Cancer

The session "Hematology in Cancer" focuses on the critical role that hematology plays in understanding, diagnosing, and treating various cancers, particularly those related to the blood. Hematology, the study of blood, blood-forming organs, and blood disorders, is central to many aspects of oncology, particularly for cancers like leukemia, lymphoma, and multiple myeloma. This session is designed to provide an exploration of hematological cancers, also known as blood cancers, and the essential role of hematologists in diagnosing and treating these complex conditions.

Understanding Hematological Cancers

Hematological cancers primarily affect the blood, bone marrow, and lymphatic system. Key types of hematological cancers include

Leukemia: A cancer of the bone marrow and blood characterized by the excessive production of abnormal white blood cells. Participants will learn about the differences between acute and chronic leukemia and how these subtypes are diagnosed and treated.

Lymphoma: The two main types are Hodgkin lymphoma, characterized by the presence of Reed-Sternberg cells, and non-Hodgkin lymphoma, which encompasses a diverse group of malignancies.

Multiple Myeloma: A cancer that forms in plasma cells, a type of white blood cell that helps fight infections. Gain insights into the latest treatment options and the challenges in managing this disease.

Pathophysiology of Hematologic Cancers: Understanding how genetic mutations, chromosomal abnormalities, and other factors contribute to the development of blood cancers.

Diagnostic Techniques: The latest advancements in hematology diagnostics, including blood tests, bone marrow biopsies, flow cytometry, and molecular testing, which are crucial for early detection and accurate classification of hematologic cancers.

Treatment Approaches: Exploring cutting-edge therapies for blood cancers, including chemotherapy, radiation therapy, targeted therapy, and stem cell transplantation.

Immunotherapy in Hematologic Cancers: The role of immunotherapies such as CAR T-cell therapy and monoclonal antibodies in treating blood cancers and how these treatments are revolutionizing outcomes for patients.

Bone Marrow and Stem Cell Transplants: Discussing the use of hematopoietic stem cell transplantation as a curative option for certain blood cancers and the advances in donor matching and graft-versus-host disease management.

To feature presentations among leading experts, case studies and discussions, submit your abstract at our Cancer Conference.

4th International Conference on Cancer Science and Therapy

Track: Hematology in Cancer

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at